These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 39263327)
1. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids. Correia de Sousa M; Delangre E; Berthou F; El Harane S; Maeder C; Fournier M; Krause KH; Gjorgjieva M; Foti M JHEP Rep; 2024 Sep; 6(9):101126. PubMed ID: 39263327 [TBL] [Abstract][Full Text] [Related]
3. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice. Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis. Wan Z; Liu X; Yang X; Huang Z; Chen X; Feng Q; Cao H; Deng H Cell Mol Life Sci; 2024 Sep; 81(1):398. PubMed ID: 39261317 [TBL] [Abstract][Full Text] [Related]
5. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice. Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2. Li B; Yang Z; Mao F; Gong W; Su Q; Yang J; Liu B; Song Y; Jin J; Lu Y J Hepatol; 2023 Nov; 79(5):1096-1109. PubMed ID: 37463623 [TBL] [Abstract][Full Text] [Related]
7. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH. Liu YJ; Kimura M; Li X; Sulc J; Wang Q; Rodríguez-López S; Scantlebery AML; Strotjohann K; Gallart-Ayala H; Vijayakumar A; Myers RP; Ivanisevic J; Houtkooper RH; Subramanian GM; Takebe T; Auwerx J J Hepatol; 2024 Aug; ():. PubMed ID: 39181211 [TBL] [Abstract][Full Text] [Related]
8. Tenascin-X is increased with decreased expression of miR-378a-5p and miR-486-5p in mice fed a methionine-choline-deficient diet that induces hepatic fibrosis. Matsumoto KI; Higuchi T; Umeki M; Ono M; Sakamoto S Biomed Res; 2024; 45(2):67-76. PubMed ID: 38556264 [TBL] [Abstract][Full Text] [Related]
9. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment. Tobaruela-Resola AL; Milagro FI; Elorz M; Benito-Boillos A; Herrero JI; Mogna-Peláez P; Tur JA; Martínez JA; Abete I; Zulet MÁ J Physiol Biochem; 2024 Aug; ():. PubMed ID: 39138826 [TBL] [Abstract][Full Text] [Related]
10. miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. Fernández-Tussy P; Cardelo MP; Zhang H; Sun J; Price NL; Boutagy NE; Goedeke L; Cadena-Sandoval M; Xirouchaki CE; Brown W; Yang X; Pastor-Rojo O; Haeusler RA; Bennett AM; Tiganis T; Suárez Y; Fernández-Hernando C JCI Insight; 2024 Aug; 9(19):. PubMed ID: 39190492 [TBL] [Abstract][Full Text] [Related]
11. ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism. Luo J; Lu Z; Zhong Z; Pi M; Xiong Y; Li L; Chen T; Chen Y; Wang CY; Liu Z; Ye Q Free Radic Biol Med; 2024 Feb; 212():34-48. PubMed ID: 38104741 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles. Seok JK; Yang G; Jee JI; Kang HC; Cho YY; Lee HS; Lee JY Toxicol Res; 2024 Oct; 40(4):683-695. PubMed ID: 39345739 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis. Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic siRNA targeting PLIN2 ameliorates steatosis, inflammation, and fibrosis in steatotic liver disease models. Wang Y; Zhou J; Yang Q; Li X; Qiu Y; Zhang Y; Liu M; Zhu AJ J Lipid Res; 2024 Aug; 65(10):100635. PubMed ID: 39187042 [TBL] [Abstract][Full Text] [Related]
15. Repurposing of the analgesic Neurotropin for MASLD/MASH treatment. Tsuchiya T; Kim SY; Matsuda M; Kim J; Stotland A; Naiki M; Seki E Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39023282 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. Zhang B; Li H; Li D; Sun H; Li M; Hu H Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698 [TBL] [Abstract][Full Text] [Related]